InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15) |
XSDQTOBWRPYKKA-UHFFFAOYSA-N |
NC(=N)NC(=O)c1nc(Cl)c(N)nc1N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
sodium channel blocker
An agent that inhibits sodium influx through cell membranes.
|
|
diuretic
An agent that promotes the excretion of urine through its effects on kidney function.
|
|
View more via ChEBI Ontology
3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide
|
amilorida
|
ChemIDplus
|
amiloride
|
WHO MedNet
|
amiloride
|
ChEBI
|
amiloridum
|
ChemIDplus
|
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
|
IUPAC
|
Amiloride
|
KEGG COMPOUND
|
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
|
ChemIDplus
|
158
|
DrugCentral
|
Amiloride
|
Wikipedia
|
AMR
|
PDBeChem
|
BE639386
|
Patent
|
C06821
|
KEGG COMPOUND
|
CPD-10324
|
MetaCyc
|
D07447
|
KEGG DRUG
|
DB00594
|
DrugBank
|
HMDB0014732
|
HMDB
|
LSM-4194
|
LINCS
|
US3313813
|
Patent
|
View more database links |
2609-46-3
|
CAS Registry Number
|
ChemIDplus
|
616612
|
Beilstein Registry Number
|
Beilstein
|
657410
|
Reaxys Registry Number
|
Reaxys
|
|